- Home
- SVIA vs RLMD Comparison
SVIA vs RLMD Comparison
Compare SVIA & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVIA | RLMD |
|---|---|---|
| Founded | 2025 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.9M | 348.8M |
| IPO Year | 2026 | 2012 |
Fundamental Metrics
Financial Performance| Metric | SVIA | RLMD |
|---|---|---|
| Price | $2.99 | $3.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 995.1K | ★ 1.8M |
| Earning Date | 11-18-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.28 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $13,070.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 154.83 |
| 52 Week Low | $2.81 | $2.65 |
| 52 Week High | $4.74 | $8.00 |
Technical Indicators
Market Signals| Indicator | SVIA | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 36.58 | 57.62 |
| Support Level | $2.81 | $3.13 |
| Resistance Level | $3.89 | $4.35 |
| Average True Range (ATR) | 0.28 | 0.29 |
| MACD | -0.05 | 0.11 |
| Stochastic Oscillator | 17.13 | 56.21 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.